Paul McPherson

Papers

Total Citations

235

H-Index

About

Paul McPherson is a leading translational neuroscientist whose work has fundamentally advanced the early detection and management of acute ischemic stroke. His landmark 2003 study, "Early Biomarkers of Stroke," which has garnered over 235 citations, directly addressed a critical clinical gap: the lack of rapid, sensitive diagnostic assays for use in emergency settings. While CT scans remain the standard for ruling out hemorrhagic stroke, McPherson’s research highlighted their profound limitations—less than 33% sensitivity—in detecting ischemic events, thereby catalyzing a shift toward blood-based biomarker discovery. This foundational contribution has shaped subsequent efforts to develop point-of-care diagnostics that can accelerate thrombolytic therapy and improve patient outcomes. Beyond this seminal work, McPherson’s broader research portfolio continues to explore novel molecular signatures of neural injury, bridging bench science with bedside application. His impact is measured not only in citations but in the tangible influence his findings have had on clinical protocols and the design of emergency stroke trials. For students and researchers, McPherson exemplifies how a single, well-executed study can redefine a field’s priorities and save lives.